NAD+ 500 mg

Nicotinamide adenine dinucleotide, commonly abbreviated as NAD+, is a nucleotide-derived research cofactor involved in cellular redox reactions and molecular energy-transfer pathways.

NAD+ is not a peptide. Its structure contains nicotinamide and adenine nucleotide components connected through phosphate groups.

Controlled experimental research involving NAD+ includes redox chemistry, enzymatic interactions, cellular energetics, molecular signaling, and metabolic-pathway models.

Each vial contains 500 mg of NAD+ research material. Batch-specific analytical documentation should be consulted for identity, chemical form, purity, water content, and specifications of the applicable tested lot.

For research use only. Not for human or veterinary use, administration, or consumption. This product is not approved by the FDA and is not intended to diagnose, treat, cure, or prevent any disease.

NAD+ has been examined in experimental research involving oxidation-reduction reactions, enzyme-dependent molecular processes, cellular energetics, and metabolic signaling.

The chemical form, hydration state, counterions, and degradation products can affect the analytical specifications of NAD+ research material.

Available findings do not establish human safety, efficacy, dosing, increased energy, improved recovery, anti-aging effects, longevity benefits, or therapeutic use.

References to published literature are provided for scientific context only and do not constitute medical advice or a claim of efficacy.

Packaging

Vials are lyophilized, sealed, and shipped in insulated, temperature-controlled packaging where applicable.

Delivery

In-stock orders are prepared for dispatch on business days. Domestic transit is typically 2–5 business days depending on the service selected at checkout.

Storage on arrival

Store lyophilized at -20°C, protected from light and moisture. Store according to the product-specific laboratory storage specifications and applicable analytical documentation.